Moderna Inc at Jefferies London Healthcare Conference Transcript
Thanks for joining us on our next session. I'm Michael Yee, Senior Biotechnology Analyst at Jefferies. Very happy to have up here on the stage the President of Moderna, Stephen Hoge. It's great to have you. Thanks for being here with us.
Questions & Answers
Obviously, a ton of stuff going on. You just reported earnings. We're in the middle of some sort of transition from pandemic to endemic. I think we were commenting here, I guess, we are in endemic because everyone is doing just fine, and we'll deal with that. But also, of course, a lot of important things near term on the platform.
And so I'd love to spend some time talking about, obviously, where we are with COVID and some of the big platform readouts that are going to happen, because I think this is as important as perhaps the Moderna story will obviously have exposure to COVID, but transition to talking about other things.
So maybe
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |